Rebecca Badawi1 and Georges El Hachem2*
1Department of Internal Medicine, Saint George Hospital University Medical Center, Beirut, Lebanon
2Department of Hematology/Medical Oncology, Saint George Hospital University Medical Center, Beirut, Lebanon
*Corresponding Author: Georges El Hachem, Hematologist and Medical Oncologist, Saint George Hospital University Medical Center and Assistant Professor of Clinical Medicine, University of Balamand, Beirut Lebanon.
Received: August 16, 2020; Published: August 24, 2020
Tuesday August 4th, 2020 at 6:08 PM: a date to be forever engraved in every Lebanese heart. A tranquil and undisturbed Beirut betrayed by the uproar of what seemed to be sounds of fireworks at first to turn into a 6-mile radius disaster at a blink of an eye. Unconfirmed reports to the whereabouts of the explosion started to be released to finally pin the location at a warehouse in Beirut’s port. The underlying cause of this disaster is still unknown but what we do know is its repercussions. Catastrophic the least we can say, its aftermath left over 171 confirmed deaths with 30 additional missing; more than 6000 people injured ranging from superficial cuts to debilitating wounds and more than 300,000 individuals displaced.
Citation: Rebecca Badawi and Georges El Hachem. “Beirut Blast: How Medical Oncology is Facing a Crisis after Crisis”.Acta Scientific Cancer Biology 4.9 (2020): 27-28.
Copyright: © 2020 Rebecca Badawi and Georges El Hachem. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.